It should be noted that the PSP clinical subtypes have specific patterns of progressive tau accumulation and associated neuronal degeneration and that the non-neuronal cell types affected depend on clinical presentation (Kovacs et al., 2020). Here, MAPT is linked to supranuclear palsy, progressive, 1.